Year |
Citation |
Score |
2020 |
Youngblood BA, Leung J, Falahati R, Williams J, Schanin J, Brock EC, Singh B, Chang AT, O'Sullivan JA, Schleimer RP, Tomasevic N, Bebbington CR, Bochner BS. Discovery, Function, and Therapeutic Targeting of Siglec-8. Cells. 10. PMID 33374255 DOI: 10.3390/cells10010019 |
0.411 |
|
2020 |
Schanin J, Gebremeskel S, Korver W, Falahati R, Butuci M, Haw TJ, Nair PM, Liu G, Hansbro NG, Hansbro PM, Evensen E, Brock EC, Xu A, Wong A, Leung J, et al. A monoclonal antibody to Siglec-8 suppresses non-allergic airway inflammation and inhibits IgE-independent mast cell activation. Mucosal Immunology. PMID 32814824 DOI: 10.1038/S41385-020-00336-9 |
0.353 |
|
2019 |
Youngblood BA, Brock EC, Leung J, Falahati R, Bochner BS, Rasmussen HS, Peterson K, Bebbington C, Tomasevic N. Siglec-8 antibody reduces eosinophil and mast cell infiltration in a transgenic mouse model of eosinophilic gastroenteritis. Jci Insight. PMID 31465299 DOI: 10.1172/Jci.Insight.126219 |
0.374 |
|
2019 |
Youngblood BA, Brock EC, Leung J, Falahati R, Bryce PJ, Bright J, Williams J, Shultz LD, Greiner DL, Brehm MA, Bebbington C, Tomasevic N. AK002, a Humanized Sialic Acid-Binding Immunoglobulin-Like Lectin-8 Antibody that Induces Antibody-Dependent Cell-Mediated Cytotoxicity against Human Eosinophils and Inhibits Mast Cell-Mediated Anaphylaxis in Mice. International Archives of Allergy and Immunology. 1-12. PMID 31401630 DOI: 10.1159/000501637 |
0.407 |
|
2016 |
Bryce PJ, Falahati R, Kenney LL, Leung J, Bebbington C, Tomasevic N, Krier RA, Hsu CL, Shultz LD, Greiner DL, Brehm MA. Humanized mouse model of mast cell-mediated passive cutaneous anaphylaxis and passive systemic anaphylaxis. The Journal of Allergy and Clinical Immunology. PMID 27139822 DOI: 10.1016/J.Jaci.2016.01.049 |
0.341 |
|
2015 |
Falahati R, Bright J, Dorenbaum A, Bebbington C, Tomasevic N, Lidke D, George TI, Gotlib J. A Recombinant Antibody to Siglec-8 Shows Selective ADCC Activity Against Mast Cells from Systemic Mastocytosis Patients Blood. 126: 4092-4092. DOI: 10.1182/Blood.V126.23.4092.4092 |
0.468 |
|
2013 |
Shi Y, Falahati R, Zhang J, Flebbe-Rehwaldt L, Gaensler KML. Role of antigen-specific regulatory CD4+ CD25+ T cells in tolerance induction after neonatal IP administration of AAV-hF.IX Gene Therapy. 20: 987-996. PMID 23759700 DOI: 10.1038/Gt.2013.22 |
0.59 |
|
2012 |
Falahati R, Zhang J, Flebbe-Rehwaldt L, Shi Y, Gerson SL, Gaensler KM. Chemoselection of allogeneic HSC after murine neonatal transplantation without myeloablation or post-transplant immunosuppression. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 2180-9. PMID 22871662 DOI: 10.1038/Mt.2012.136 |
0.342 |
|
2011 |
Jales A, Falahati R, Mari E, Stemmy EJ, Shen W, Southammakosane C, Herzog D, Ladisch S, Leitenberg D. Ganglioside-exposed dendritic cells inhibit T-cell effector function by promoting regulatory cell activity. Immunology. 132: 134-43. PMID 20875076 DOI: 10.1111/J.1365-2567.2010.03348.X |
0.567 |
|
2009 |
Hacke K, Falahati R, Flebbe-Rehwaldt L, Kasahara N, Gaensler KM. Suppression of HLA expression by lentivirus-mediated gene transfer of siRNA cassettes and in vivo chemoselection to enhance hematopoietic stem cell transplantation. Immunologic Research. 44: 112-26. PMID 19048410 DOI: 10.1007/S12026-008-8088-Z |
0.373 |
|
2008 |
Falahati R, Leitenberg D. Selective regulation of TCR signaling pathways by the CD45 protein tyrosine phosphatase during thymocyte development. Journal of Immunology (Baltimore, Md. : 1950). 181: 6082-91. PMID 18941197 DOI: 10.4049/Jimmunol.181.9.6082 |
0.745 |
|
2007 |
Leitenberg D, Falahati R, Lu DD, Takeda A. CD45-associated protein promotes the response of primary CD4 T cells to low-potency T-cell receptor (TCR) stimulation and facilitates CD45 association with CD3/TCR and lck. Immunology. 121: 545-54. PMID 17428310 DOI: 10.1111/J.1365-2567.2007.02602.X |
0.757 |
|
2007 |
Falahati R, Leitenberg D. Changes in the role of the CD45 protein tyrosine phosphatase in regulating Lck tyrosine phosphorylation during thymic development. Journal of Immunology (Baltimore, Md. : 1950). 178: 2056-64. PMID 17277109 DOI: 10.4049/Jimmunol.178.4.2056 |
0.726 |
|
2006 |
Gwinn WM, Damsker JM, Falahati R, Okwumabua I, Kelly-Welch A, Keegan AD, Vanpouille C, Lee JJ, Dent LA, Leitenberg D, Bukrinsky MI, Constant SL. Novel approach to inhibit asthma-mediated lung inflammation using anti-CD147 intervention. Journal of Immunology (Baltimore, Md. : 1950). 177: 4870-9. PMID 16982929 DOI: 10.4049/Jimmunol.177.7.4870 |
0.737 |
|
2005 |
Shen W, Falahati R, Stark R, Leitenberg D, Ladisch S. Modulation of CD4 Th cell differentiation by ganglioside GD1a in vitro. Journal of Immunology (Baltimore, Md. : 1950). 175: 4927-34. PMID 16210594 DOI: 10.4049/Jimmunol.175.8.4927 |
0.695 |
|
2005 |
Kwon J, Qu CK, Maeng JS, Falahati R, Lee C, Williams MS. Receptor-stimulated oxidation of SHP-2 promotes T-cell adhesion through SLP-76-ADAP. The Embo Journal. 24: 2331-41. PMID 15933714 DOI: 10.1038/Sj.Emboj.7600706 |
0.436 |
|
Show low-probability matches. |